Literature DB >> 9482923

Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner.

P M Oliver1, S W John, K E Purdy, R Kim, N Maeda, M F Goy, O Smithies.   

Abstract

Activation of the natriuretic peptide system lowers blood pressure and causes the excretion of salt. Atrial natriuretic peptide and B-type natriuretic peptide are the humoral mediators of this effect; they act primarily by binding to membrane-bound natriuretic peptide receptor A (NPRA) and stimulating its intrinsic guanylate cyclase activity. To study whether genetically determined differences in NPRA expression affect blood pressure we have generated mice with one, two, three, or four copies of the gene encoding NPRA (Npr1 in the mouse). Atrial natriuretic peptide-dependent guanylate cyclase activity ranged progressively from approximately one-half normal in one-copy animals to twice normal in four-copy animals (P < 0.001). On different diets (0.05%, 2%, and 8% NaCl), the blood pressures of F1 male mice having only one copy of Npr1 averaged 9.1 mmHg (1 mmHg = 133 Pa) above those of wild-type two-copy males (P < 0.001), whereas males with three copies of the gene had blood pressures averaging 5.2 mmHg below normal (P < 0.01). The blood pressures of the one-copy F1 animals were significantly higher (by 6.2 mmHg; P < 0.01) on the high-salt than on the low-salt diet. The blood pressures of four-copy F3 males were significantly lower (by 7 mmHg; P < 0.05) on the high-salt than on the low-salt diet. These results demonstrate that below normal Npr1 expression leads to a salt-sensitive increase in blood pressure, whereas above normal Npr1 expression lowers blood pressures and protects against high dietary salt.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482923      PMCID: PMC19408          DOI: 10.1073/pnas.95.5.2547

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis.

Authors:  J H Krege; H S Kim; J S Moyer; J C Jennette; L Peng; S K Hiller; O Smithies
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

2.  Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides.

Authors:  A L Steiner; C W Parker; D M Kipnis
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

3.  A comprehensive genetic map of the mouse genome.

Authors:  W F Dietrich; J Miller; R Steen; M A Merchant; D Damron-Boles; Z Husain; R Dredge; M J Daly; K A Ingalls; T J O'Connor
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

4.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

Authors:  A J de Bold; H B Borenstein; A T Veress; H Sonnenberg
Journal:  Life Sci       Date:  1981-01-05       Impact factor: 5.037

5.  A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.

Authors:  I Inoue; T Nakajima; C S Williams; J Quackenbush; R Puryear; M Powers; T Cheng; E H Ludwig; A M Sharma; A Hata; X Jeunemaitre; J M Lalouel
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

6.  Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide.

Authors:  M J Lopez; S K Wong; I Kishimoto; S Dubois; V Mach; J Friesen; D L Garbers; A Beuve
Journal:  Nature       Date:  1995-11-02       Impact factor: 49.962

7.  Genetic control of blood pressure and the angiotensinogen locus.

Authors:  H S Kim; J H Krege; K D Kluckman; J R Hagaman; J B Hodgin; C F Best; J C Jennette; T M Coffman; N Maeda; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension.

Authors:  S W John; J H Krege; P M Oliver; J R Hagaman; J B Hodgin; S C Pang; T G Flynn; O Smithies
Journal:  Science       Date:  1995-02-03       Impact factor: 47.728

Review 9.  Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension.

Authors:  O Smithies; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

Review 10.  Molecular genetics of human blood pressure variation.

Authors:  R P Lifton
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

View more
  50 in total

1.  Natriuretic peptide receptors and the heart.

Authors:  L King; M R Wilkins
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

2.  Salt-sensitive hypertension: if only it were as simple as rocket science.

Authors:  Timothy L Reudelhuber
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates renal (pro) renin receptor expression in Npr1 null mutant mice.

Authors:  Ramu Periyasamy; Subhankar Das; Kailash N Pandey
Journal:  Peptides       Date:  2019-04-06       Impact factor: 3.750

4.  Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes the vascular endothelial growth factor-stimulated MAPKs and downstream effectors AP-1 and CREB in mouse mesangial cells.

Authors:  Satyabha Tripathi; Kailash N Pandey
Journal:  Mol Cell Biochem       Date:  2012-05-19       Impact factor: 3.396

Review 5.  Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.

Authors:  Kailash N Pandey
Journal:  Can J Physiol Pharmacol       Date:  2011-08-04       Impact factor: 2.273

6.  Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1.

Authors:  Prerna Kumar; Satyabha Tripathi; Kailash N Pandey
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

7.  Inhibition of HDAC enhances STAT acetylation, blocks NF-κB, and suppresses the renal inflammation and fibrosis in Npr1 haplotype male mice.

Authors:  Prerna Kumar; Venkateswara R Gogulamudi; Ramu Periasamy; Giri Raghavaraju; Umadevi Subramanian; Kailash N Pandey
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-31

8.  ANP-mediated inhibition of distal nephron fractional sodium reabsorption in wild-type and mice overexpressing natriuretic peptide receptor.

Authors:  Di Zhao; Kailash N Pandey; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

9.  Retinoic acid and sodium butyrate suppress the cardiac expression of hypertrophic markers and proinflammatory mediators in Npr1 gene-disrupted haplotype mice.

Authors:  Umadevi Subramanian; Prerna Kumar; Indra Mani; David Chen; Isaac Kessler; Ramu Periyasamy; Giri Raghavaraju; Kailash N Pandey
Journal:  Physiol Genomics       Date:  2016-05-06       Impact factor: 3.107

10.  Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development.

Authors:  Nicola J A Scott; Leigh J Ellmers; John G Lainchbury; Nobuyo Maeda; Oliver Smithies; A Mark Richards; Vicky A Cameron
Journal:  Biochim Biophys Acta       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.